TABLE 3.
FT females n = 200 | Frequent FT females n = 114 | HI females n = 92 | FT males n = 200 | Deferred males n = 33 | HI males n = 136 | |||
Longitudinal cohort | HFE C282Y | Wild type | 180 (90%) | 185 (93%) | 103 (90%) | 27 (82%) | 80 (87%) | 124 (91%) |
Heterozygous | 20 (10%) | 14 (7%) | 11 (10%) | 6 (18%) | 12 (13%) | 12 (9%) | ||
Homozygous | 0 (0%) | 1 (1%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
HFE H63D | Wild type | 142 (71%) | 141 (71%) | 81 (71%) | 25 (76%) | 67 (73%) | 104 (76%) | |
Heterozygous | 53 (27%) | 58 (29%) | 32 (28%) | 8 (24%) | 23 (25%) | 31 (23%) | ||
Homozygous | 5 (3%) | 1 (1%) | 1 (1%) | 0 (0%) | 2 (2%) | 1 (1%) | ||
TMPRSS6 A736V | Wild type | 81 (41%) | 33 (29%) | 27 (29%) | 79 (40%) | 9 (27%) | 40 (29%) | |
Heterozygous | 86 (43%) | 62 (54%) | 49 (53%) | 82 (41%) | 14 (42%) | 61 (45%) | ||
Homozygous | 33 (17%) | 19 (17%) | 16 (17%) | 39 (20%) | 10 (30%) | 35 (26%) | ||
FT females n = 2055 | Frequent FT females n = 762 | HI females n = 788 | FT males n = 1713 | Deferred males n = 180 | HI males n = 1575 | |||
Cross-sectional cohort | HFE C282Y | Wild type | 1923 (87.5%) | 687 (85.1%) | 693 (84.7%) | 1600 (88.9%) | 162 (88.5%) | 1411 (85.4%) |
Heterozygous | 118 (5.4%) | 73 (9%) | 91 (11.1%) | 91 (5.1%) | 18 (9.8%) | 156 (9.4%) | ||
Homozygous | 14 (0.6%) | 2 (0.2%) | 4 (0.5%) | 22 (1.2%) | 0 (0%) | 8 (0.5%) | ||
HFE H63D | Wild type | 1645 (74.8%) | 571 (70.8%) | 587 (71.8%) | 1366 (75.9%) | 131 (71.6%) | 1146 (69.4%) | |
Heterozygous | 383 (17.4%) | 175 (21.7%) | 177 (21.6%) | 319 (17.7%) | 44 (24%) | 396 (24%) | ||
Homozygous | 27 (1.2%) | 16 (2%) | 24 (2.9%) | 28 (1.6%) | 5 (2.7%) | 33 (2%) | ||
TMPRSS6 A736V | Wild type | 759 (34.5%) | 289 (35.8%) | 272 (33.3%) | 621 (34.5%) | 60 (32.8%) | 553 (33.5%) | |
Heterozygous | 923 (42%) | 347 (43%) | 397 (48.5%) | 778 (43.2%) | 83 (45.4%) | 748 (45.3%) | ||
Homozygous | 373 (17%) | 126 (15.6%) | 119 (14.5%) | 314 (17.4%) | 37 (20.2%) | 274 (16.6%) |